Potentiated adrenomedullin-induced vasorelaxation during hypoxia in organ cultured porcine coronary arteries
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Potentiated adrenomedullin-induced vasorelaxation during hypoxia in organ cultured porcine coronary arteries. / Hasbak, Philip; Sheykhzade, Majid; Schifter, Søren; Edvinsson, Lars.
In: Journal of Cardiovascular Pharmacology, Vol. 63, No. 1, 01.2014, p. 58-67.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Potentiated adrenomedullin-induced vasorelaxation during hypoxia in organ cultured porcine coronary arteries
AU - Hasbak, Philip
AU - Sheykhzade, Majid
AU - Schifter, Søren
AU - Edvinsson, Lars
PY - 2014/1
Y1 - 2014/1
N2 - This study describes the effect of variable oxygen supply on relaxing responses induced by αCGRP and adrenomedullin (AM) on isolated pig coronary arteries in vitro. Organ culture during normoxia (21% O2) and hypoxia (5% O2) induced a significant leftward shift of the AM concentration-response curves compared to fresh vessels altering the pEC50 values from 6.9 ± 0.04 to 8.0 ± 0.04, whereas the potency (pEC50) of αCGRP was attenuated from 8.8 ± 0.04 to 7.6 ± 0.04. AM22-52 exerted significant antagonistic effect on AM-induced vasorelaxation in hypoxic and normoxic conditions (apparent pKB = 6.8 - 7.2), whereas no antagonistic effect was observed in fresh and hyperoxic (95 %) organ cultured vessels. The antagonistic effect exerted by αCGRP8-37 (10 - 10 M) on αCGRP-induced vasodilatation in fresh vessels (derived from Schild plot pA2 = 7.4 ± 0.1) was unaltered during organ culture. The antagonistic effect exerted by αCGRP8-37 (10M) on AM-induced vasorelaxation in fresh vessels (apparent pKB = 7.4 ± 0.1) was absent during hypoxic organ culture. TheRAMP1/Calcitonin like receptor (CLR) mRNA ratio was reduced and RAMP2/CLR mRNA ratio increased during hypoxic and normoxic organ culture compared to fresh vessels. Hypoxic organ culture for 24h - 72h potentiated the AM induced vasorelaxation via an AM22-52 sensitive receptor but attenuated the vasorelaxant effect of CGRP via the CGRP receptors. This could possibly be explained by relatively decreased levels of RAMP1, thus favoring RAMP2 + CLR complex (= AM receptor) formation during hypoxic organ culture.
AB - This study describes the effect of variable oxygen supply on relaxing responses induced by αCGRP and adrenomedullin (AM) on isolated pig coronary arteries in vitro. Organ culture during normoxia (21% O2) and hypoxia (5% O2) induced a significant leftward shift of the AM concentration-response curves compared to fresh vessels altering the pEC50 values from 6.9 ± 0.04 to 8.0 ± 0.04, whereas the potency (pEC50) of αCGRP was attenuated from 8.8 ± 0.04 to 7.6 ± 0.04. AM22-52 exerted significant antagonistic effect on AM-induced vasorelaxation in hypoxic and normoxic conditions (apparent pKB = 6.8 - 7.2), whereas no antagonistic effect was observed in fresh and hyperoxic (95 %) organ cultured vessels. The antagonistic effect exerted by αCGRP8-37 (10 - 10 M) on αCGRP-induced vasodilatation in fresh vessels (derived from Schild plot pA2 = 7.4 ± 0.1) was unaltered during organ culture. The antagonistic effect exerted by αCGRP8-37 (10M) on AM-induced vasorelaxation in fresh vessels (apparent pKB = 7.4 ± 0.1) was absent during hypoxic organ culture. TheRAMP1/Calcitonin like receptor (CLR) mRNA ratio was reduced and RAMP2/CLR mRNA ratio increased during hypoxic and normoxic organ culture compared to fresh vessels. Hypoxic organ culture for 24h - 72h potentiated the AM induced vasorelaxation via an AM22-52 sensitive receptor but attenuated the vasorelaxant effect of CGRP via the CGRP receptors. This could possibly be explained by relatively decreased levels of RAMP1, thus favoring RAMP2 + CLR complex (= AM receptor) formation during hypoxic organ culture.
U2 - 10.1097/FJC.0000000000000025
DO - 10.1097/FJC.0000000000000025
M3 - Journal article
C2 - 24084221
VL - 63
SP - 58
EP - 67
JO - Journal of Cardiovascular Pharmacology
JF - Journal of Cardiovascular Pharmacology
SN - 0160-2446
IS - 1
ER -
ID: 92540628